Alburo, Jerly L.
HRN: 23-11-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2023
CEFUROXIME 500MG (TAB)
05/24/2023
05/31/2023
PO
500mg
BID X 7days
Thinly MSAF; UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes